104 related articles for article (PubMed ID: 20006667)
1. Liver transplant recipients weaned off immunosuppression lack circulating donor-specific antibodies.
Girnita A; Mazariegos GV; Castellaneta A; Reyes J; Bentlejewski C; Thomson AW; Zeevi A
Hum Immunol; 2010 Mar; 71(3):274-6. PubMed ID: 20006667
[TBL] [Abstract][Full Text] [Related]
2. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
3. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
Bućin D; Johansson S; Lindberg LO
Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
[TBL] [Abstract][Full Text] [Related]
4. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
[TBL] [Abstract][Full Text] [Related]
5. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
[TBL] [Abstract][Full Text] [Related]
6. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
7. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
[TBL] [Abstract][Full Text] [Related]
8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
9. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
10. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
Cardarelli F; Pascual M; Tolkoff-Rubin N; Delmonico FL; Wong W; Schoenfeld DA; Zhang H; Cosimi AB; Saidman SL
Transpl Int; 2005 May; 18(5):532-40. PubMed ID: 15819801
[TBL] [Abstract][Full Text] [Related]
13. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
14. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
[TBL] [Abstract][Full Text] [Related]
16. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
17. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
Cai J
Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
[TBL] [Abstract][Full Text] [Related]
18. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
20. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
